SAMD15
gene geneOn this page
Also known as FLJ35963
Summary
SAMD15 (sterile alpha motif domain containing 15, HGNC:18631) is a protein-coding gene on chromosome 14q24.3, encoding Sterile alpha motif domain-containing protein 15 (Q9P1V8).
Predicted to enable protein serine/threonine kinase activator activity. Predicted to be involved in signal transduction.
Source: NCBI Gene 161394 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 97 total
- MANE Select transcript:
NM_001010860
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18631 |
| Approved symbol | SAMD15 |
| Name | sterile alpha motif domain containing 15 |
| Location | 14q24.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ35963 |
| Ensembl gene | ENSG00000100583 |
| Ensembl biotype | protein_coding |
| Entrez | 161394 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000216471, ENST00000533095
RefSeq mRNA: 1 — MANE Select: NM_001010860
NM_001010860
CCDS: CCDS32126
Canonical transcript exons
ENST00000216471 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000659302 | 77377379 | 77379107 |
| ENSE00000659304 | 77391008 | 77392163 |
| ENSE00003545365 | 77380383 | 77380481 |
Expression profiles
Bgee: expression breadth ubiquitous, 160 present calls, max score 87.88.
FANTOM5 (CAGE): breadth broad, TPM avg 2.0398 / max 92.7700, expressed in 792 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 140779 | 1.8241 | 711 |
| 140778 | 0.2157 | 81 |
Top tissues by expression
249 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 87.88 | gold quality |
| gingival epithelium | UBERON:0001949 | 84.27 | gold quality |
| superficial temporal artery | UBERON:0001614 | 84.13 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 83.57 | silver quality |
| mammary duct | UBERON:0001765 | 82.71 | silver quality |
| epithelium of mammary gland | UBERON:0003244 | 82.49 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 82.32 | gold quality |
| left testis | UBERON:0004533 | 81.48 | gold quality |
| buccal mucosa cell | CL:0002336 | 81.35 | gold quality |
| right testis | UBERON:0004534 | 80.96 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 80.86 | gold quality |
| testis | UBERON:0000473 | 79.69 | gold quality |
| gingiva | UBERON:0001828 | 76.60 | gold quality |
| right uterine tube | UBERON:0001302 | 74.04 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 71.31 | gold quality |
| bronchial epithelial cell | CL:0002328 | 71.21 | gold quality |
| ventricular zone | UBERON:0003053 | 70.93 | gold quality |
| bronchus | UBERON:0002185 | 70.47 | gold quality |
| amniotic fluid | UBERON:0000173 | 67.20 | gold quality |
| islet of Langerhans | UBERON:0000006 | 67.08 | gold quality |
| cortical plate | UBERON:0005343 | 67.03 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 65.03 | gold quality |
| prefrontal cortex | UBERON:0000451 | 64.97 | gold quality |
| pituitary gland | UBERON:0000007 | 64.92 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 64.89 | gold quality |
| adenohypophysis | UBERON:0002196 | 64.52 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 63.74 | gold quality |
| nucleus accumbens | UBERON:0001882 | 63.27 | gold quality |
| lower lobe of lung | UBERON:0008949 | 63.18 | silver quality |
| right lobe of thyroid gland | UBERON:0001119 | 63.16 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.25 |
Regulation
Is transcription factor: no
Cross-species orthologs
6 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Samd15 | ENSMUSG00000090812 |
| rattus_norvegicus | Samd15 | ENSRNOG00000050413 |
| drosophila_melanogaster | Cp190 | FBGN0000283 |
| drosophila_melanogaster | CG9915 | FBGN0030738 |
| drosophila_melanogaster | CG12592 | FBGN0037811 |
| caenorhabditis_elegans | WBGENE00008729 |
Paralogs (3): MDN1 (ENSG00000112159), IWS1 (ENSG00000163166), TCHHL1 (ENSG00000182898)
Protein
Protein identifiers
Sterile alpha motif domain-containing protein 15 — Q9P1V8 (reviewed: Q9P1V8)
All UniProt accessions (2): Q9P1V8, G3V2Z3
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9P1V8-1 | 1 | yes |
| Q9P1V8-2 | 2 |
RefSeq proteins (1): NP_001010860* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001660 | SAM | Domain |
| IPR013761 | SAM/pointed_sf | Homologous_superfamily |
Pfam: PF07647
UniProt features (18 total): compositionally biased region 9, sequence variant 4, splice variant 2, chain 1, domain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9P1V8-F1 | 49.54 | 0.11 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 27 (showing top):
GOMF_KINASE_ACTIVATOR_ACTIVITY, chr14q24, GOMF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVATOR_ACTIVITY, GOMF_ENZYME_ACTIVATOR_ACTIVITY, GOMF_ENZYME_REGULATOR_ACTIVITY, DODD_NASOPHARYNGEAL_CARCINOMA_DN, ZWANG_EGF_PERSISTENTLY_DN, ELF2_TARGET_GENES, ZMYM2_TARGET_GENES, ZNF563_TARGET_GENES, ZNF711_TARGET_GENES, CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2, GSE11864_UNTREATED_VS_CSF1_PAM3CYS_IN_MAC_DN, GSE13485_DAY1_VS_DAY3_YF17D_VACCINE_PBMC_UP, GAO_ESOPHAGUS_25W_C1_CILIATED_EPITHELIAL_CELLS
GO Biological Process (1): signal transduction (GO:0007165)
GO Molecular Function (2): protein serine/threonine kinase activator activity (GO:0043539), protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| protein serine/threonine kinase activity | 1 |
| protein kinase activator activity | 1 |
| binding | 1 |
Protein interactions and networks
STRING
160 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SAMD15 | SLIRP-OT1 | Q8N769 | 657 |
| SAMD15 | TMED8 | Q6PL24 | 599 |
| SAMD15 | NOXRED1 | Q6NXP6 | 509 |
| SAMD15 | FAM153A | Q9UHL3 | 472 |
| SAMD15 | NMT2 | O60551 | 455 |
| SAMD15 | ISM2 | Q6H9L7 | 430 |
| SAMD15 | ADCK1 | Q86TW2 | 380 |
| SAMD15 | POPDC2 | Q9HBU9 | 354 |
| SAMD15 | VIPAS39 | Q9H9C1 | 325 |
| SAMD15 | ARMC2 | Q8NEN0 | 323 |
| SAMD15 | SLC12A8 | A0AV02 | 322 |
| SAMD15 | RBM43 | Q6ZSC3 | 317 |
| SAMD15 | PDZD7 | Q9H5P4 | 314 |
| SAMD15 | KAT5 | Q92993 | 306 |
| SAMD15 | SLIRP | Q9GZT3 | 303 |
IntAct
0 interactions, top by confidence:
BioGRID (1): SAMD15 (Affinity Capture-RNA)
ESM2 similar proteins: A0A1B0GUW6, A1EGX6, A4FU49, A6NJ88, A6QP92, E9PAV3, E9Q0C6, F1QU13, O94854, P18583, P24587, P27546, P27816, P36225, P43597, P70670, Q08DY0, Q2T9N0, Q32L62, Q4R729, Q4V7A4, Q5H9T9, Q5M7W5, Q5SWP3, Q5XHX6, Q5XPK0, Q659K0, Q68DN1, Q68FX6, Q69ZZ9, Q6AZ54, Q6P6B1, Q6ZRG5, Q70KF4, Q710D7, Q810T2, Q8K4E0, Q8N3K9, Q8TCU4, Q8WWL7
Diamond homologs: A8JQ65, B3LXF2, B3NYS4, B4I4Y1, B4JHJ7, B4K6T8, B4PRE2, B4R0A5, D3YWQ0, D3YXJ0, D3YZU1, D3ZEY4, E9PUQ8, F1MAB7, F4JKI3, F4JQ95, G4N7X0, G9CGD6, O08560, O75912, O94806, P09216, P10830, P16054, P34125, P52824, P54644, P90980, Q02156, Q09746, Q10024, Q13574, Q15139, Q16760, Q16975, Q1PDI2, Q4ACU6, Q52KW0, Q5KSL6, Q5XIS9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
97 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 81 |
| Likely benign | 11 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
401 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 14:77376932:GTACC:G | donor_loss | 1.0000 |
| 14:77376933:TACC:T | donor_loss | 1.0000 |
| 14:77376934:A:AG | donor_loss | 1.0000 |
| 14:77376935:CCTG:C | donor_loss | 1.0000 |
| 14:77376965:C:CA | donor_gain | 1.0000 |
| 14:77380382:GGA:G | acceptor_gain | 0.9900 |
| 14:77380382:GGAGT:G | acceptor_gain | 0.9900 |
| 14:77380479:AAGG:A | donor_loss | 0.9900 |
| 14:77380482:G:A | donor_loss | 0.9900 |
| 14:77380483:T:A | donor_loss | 0.9900 |
| 14:77389912:A:G | donor_gain | 0.9900 |
| 14:77378759:A:T | donor_gain | 0.9800 |
| 14:77380378:GACA:G | acceptor_loss | 0.9800 |
| 14:77380379:ACAG:A | acceptor_loss | 0.9800 |
| 14:77380380:C:G | acceptor_loss | 0.9800 |
| 14:77380381:A:AG | acceptor_gain | 0.9800 |
| 14:77380382:G:GG | acceptor_gain | 0.9800 |
| 14:77380484:G:GT | donor_loss | 0.9800 |
| 14:77389910:GTA:G | acceptor_gain | 0.9800 |
| 14:77389911:TAT:T | acceptor_gain | 0.9800 |
| 14:77389912:ATA:A | acceptor_gain | 0.9800 |
| 14:77376934:A:AC | donor_gain | 0.9700 |
| 14:77376935:C:CC | donor_gain | 0.9700 |
| 14:77379022:GGAC:G | donor_gain | 0.9700 |
| 14:77379063:G:GT | donor_gain | 0.9700 |
| 14:77391007:GGCA:G | acceptor_gain | 0.9700 |
| 14:77391006:A:AG | acceptor_gain | 0.9600 |
| 14:77391007:G:GG | acceptor_gain | 0.9600 |
| 14:77377033:AGCCG:A | donor_gain | 0.9500 |
| 14:77379087:C:G | donor_gain | 0.9500 |
AlphaMissense
4437 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 14:77379093:T:C | F559L | 0.988 |
| 14:77379095:C:A | F559L | 0.988 |
| 14:77379095:C:G | F559L | 0.988 |
| 14:77391158:T:C | F647L | 0.981 |
| 14:77391160:T:A | F647L | 0.981 |
| 14:77391160:T:G | F647L | 0.981 |
| 14:77379077:G:C | W553C | 0.976 |
| 14:77379077:G:T | W553C | 0.976 |
| 14:77380389:T:C | F566L | 0.975 |
| 14:77380391:T:A | F566L | 0.975 |
| 14:77380391:T:G | F566L | 0.975 |
| 14:77379075:T:A | W553R | 0.970 |
| 14:77379075:T:C | W553R | 0.970 |
| 14:77379094:T:C | F559S | 0.970 |
| 14:77380459:T:C | I589T | 0.970 |
| 14:77380401:T:C | F570L | 0.969 |
| 14:77380403:C:A | F570L | 0.969 |
| 14:77380403:C:G | F570L | 0.969 |
| 14:77380390:T:C | F566S | 0.966 |
| 14:77391056:T:C | F613L | 0.961 |
| 14:77391058:C:A | F613L | 0.961 |
| 14:77391058:C:G | F613L | 0.961 |
| 14:77379053:G:C | W545C | 0.958 |
| 14:77379053:G:T | W545C | 0.958 |
| 14:77379069:G:C | A551P | 0.950 |
| 14:77380455:G:T | G588W | 0.948 |
| 14:77380429:T:A | V579D | 0.947 |
| 14:77379076:G:C | W553S | 0.943 |
| 14:77380467:T:C | F592L | 0.942 |
| 14:77380469:T:A | F592L | 0.942 |
dbSNP variants (sampled 300 via entrez): RS1000254400 (14:77387726 A>G), RS1000306445 (14:77380217 C>A,T), RS1000354220 (14:77391567 G>A,C,T), RS1000470125 (14:77384326 A>C), RS1000604907 (14:77387231 G>A), RS1001711921 (14:77377121 C>A,T), RS1002319393 (14:77375943 C>A,G,T), RS1002320446 (14:77389312 T>A), RS1002361367 (14:77376393 T>C), RS1002564595 (14:77380117 T>A,C), RS1002645357 (14:77384953 C>G,T), RS1002745134 (14:77386917 A>G), RS1002781980 (14:77385379 A>G), RS1002805367 (14:77379807 ACTT>A), RS1002998949 (14:77378321 G>A,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004626_128 | Myeloid white cell count | 2.000000e-11 |
| GCST90002398_222 | Neutrophil count | 2.000000e-14 |
| GCST90002407_577 | White blood cell count | 1.000000e-12 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004833 | neutrophil count |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
18 total (human), top 18 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | increases expression | 2 |
| sotorasib | affects cotreatment, increases expression | 1 |
| pentanal | decreases expression | 1 |
| trametinib | affects cotreatment, increases expression | 1 |
| NVP-BKM120 | affects cotreatment, increases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Atrazine | increases expression | 1 |
| Benzo(a)pyrene | increases expression | 1 |
| Cisplatin | decreases expression | 1 |
| Dichlorodiphenyl Dichloroethylene | decreases expression | 1 |
| Diethylhexyl Phthalate | decreases expression | 1 |
| Folic Acid | decreases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Smoke | increases expression, increases abundance | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Okadaic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.